Kn. Wright et al., RETROGRADE CORONARY VENOUS INFUSION OF ETHANOL FOR ABLATION OF CANINEVENTRICULAR MYOCARDIUM, Journal of cardiovascular electrophysiology, 9(9), 1998, pp. 976-984
Introduction: Permanent cure of reentrant ventricular tachycardia (VT)
associated with coronary artery disease is difficult to achieve. Retr
ograde coronary venous infusion of ethanol for ablation of ventricular
myocardium associated with reentrant tachyarrhythmias has several pot
ential advantages, including use of physiologic mapping techniques and
production of deeper, wider necrotic zones. Methods and Results: Nine
anesthetized dogs had baseline hemodynamic measurement, left ventricu
lography, coronary arteriography, occlusive coronary venography, and p
rogrammed electrical stimulation of the right ventricular apex and out
flow tract. A balloon-tipped infusion catheter was advanced into a dis
tal coronary venous branch, the balloon slowly inflated, and pure etha
nol infused at volumes of 1.5, 3, or 5 cc. Hemodynamic measurements, a
ngiography, ventriculography, and programmed electrical stimulation we
re repeated immediately and 1 week following ablation, Formalin-perfus
ed hearts were serially sectioned and lesion volumes determined. Histo
logic examination of ablation beds then was performed. No significant
difference was found in any hemodynamic measurement before or after ab
lation, Coronary arteriograms and left ventriculograms were unchanged
after ablation. Nonsustained VT occurred in eight dogs during ethanol
infusion; however, VT was not inducible in any dog before or after abl
ation, Infusion volumes of 3 cc or more were required to produce trans
mural lesions. Conclusion: Retrograde coronary venous infusions of eth
anol using a balloon-tipped infusion catheter were effective in ablati
ng ventricular myocardium. Retrograde chemical ablation did not itself
result in inducible VT or adversely affect hemodynamic measurements o
r coronary arteries. Transmural myocardial necrosis, necessary in the
ablation of VT associated with coronary artery disease, can be produce
d by higher infusion volumes.